FAPI-04
68Ga-Fapi-04
(177Lu)-DOTA-fapi-04
HYINC-FAPI-04
N-[2-[(2S)-2-cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]-6-methoxyquinoline-4-carboxamide
NTFAPI
FAPI-46
NOTA-FAPI-46
6-[3-[4-(2-aminoacetyl)piperazin-1-yl]propoxy]-N-[2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl]quinoline-4-carboxamide
FAPI-05
FAPI-06
FAPI-07
FAPI-08
FAPI-09
FAPI-10
FAPI-11
FAPI-12
FAPI-14
FAPI-15
FAPI-2
(S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide
FAPI-SH
NH2-UAMC1110
UAMC1110
(S)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-(3-(piperazine-1-yl)propoxy)quinoline-4-carboxamide
FAPI02
(R)-N-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)-6-hydroxyquinoline-4-carboxamide
tert-butyl 6-(3-(4-Boc-piperazin-1-ypropyl-1-(methyl)amino)quinoline-4-carboxylate
N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-(3-(4-Boc-piperazin-1-yl)propyl-1-(methyl)amino)quinoline-4-carboxamide
NOTA-P-FAPI
NOTA-FAPT
FAPI-34
68Ga-Fapi
Gd-FAPI04
OncoFAP
關(guān)鍵字： FAPI-14;
南昌探真生物技術(shù)有限公司
主要業(yè)務(wù)：多肽服務(wù) ，肽核酸合成